Checkpoint Blockade in Lung Cancer and Mesothelioma-Reference-Cited by-同舟云学术

Checkpoint Blockade in Lung Cancer and Mesothelioma

Published:2017-08 Issue:3 Volume:196 Page:274-282
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Lievense Lysanne A.¹²,Sterman Daniel H.³,Cornelissen Robin¹,Aerts Joachim G.¹²

Affiliation:

1. Department of Pulmonary Medicine, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands

2. Department of Pulmonary Medicine, Amphia Hospital, Breda, the Netherlands; and

3. Division of Pulmonary, Critical Care, and Sleep Medicine, New York University (NYU) School of Medicine/NYU Langone Medical Center, New York, New York

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Link

http://www.atsjournals.org/doi/pdf/10.1164/rccm.201608-1755CI

Reference64 articles.

1. Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer

2. Malignant mesothelioma

3. Small cell lung cancer

4. Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, randomised controlled trial

5. Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combined cryoablation and PD-1 inhibitor synergistically enhance antitumor immune responses in Lewis lung adenocarcinoma mice via the PI3K/AKT/mTOR pathway;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-10

2. BUB1 inhibition sensitizes lung cancer cell lines to radiotherapy and chemoradiotherapy;2024-04-23

3. Clinical case of using combination of nivolumab and ipilimumab in first line of treatment for inoperable pleural mesothelioma;Medical alphabet;2023-12-04

4. Methods for assessment of the tumour microenvironment and immune interactions in non-small cell lung cancer. A narrative review;Frontiers in Oncology;2023-04-18

5. Progress in the cryoablation and cryoimmunotherapy for tumor;Frontiers in Immunology;2023-01-25